Ryan Specialty (NYSE:RYAN) Given New $35.00 Price Target at Piper Sandler

Ryan Specialty (NYSE:RYAN) had its price target reduced by equities researchers at Piper Sandler from $43.00 to $35.00 in a report issued on Friday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Piper Sandler’s price objective would indicate a potential upside of 12.42% from the stock’s previous close.

A number of other brokerages have also recently issued reports on RYAN. JPMorgan Chase & Co. lowered their price objective on Ryan Specialty from $49.00 to $43.00 and set an “underweight” rating for the company in a research note on Thursday, April 9th. Cantor Fitzgerald decreased their price target on Ryan Specialty from $45.00 to $40.00 and set a “neutral” rating for the company in a research note on Thursday, April 9th. Wells Fargo & Company restated an “equal weight” rating and issued a $31.00 price target (down from $42.00) on shares of Ryan Specialty in a research note on Friday. Barclays decreased their price target on Ryan Specialty from $41.00 to $39.00 and set an “overweight” rating for the company in a research note on Friday. Finally, Citigroup decreased their price target on Ryan Specialty from $60.00 to $55.00 and set a “buy” rating for the company in a research note on Monday, March 23rd. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, six have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $47.47.

Ryan Specialty Stock Down 10.5%

NYSE:RYAN traded down $3.64 during trading hours on Friday, reaching $31.13. 3,655,145 shares of the company traded hands, compared to its average volume of 2,105,130. The business’s 50-day moving average price is $36.08 and its two-hundred day moving average price is $46.46. The stock has a market capitalization of $8.23 billion, a P/E ratio of 74.44, a P/E/G ratio of 0.95 and a beta of 0.71. Ryan Specialty has a 1 year low of $29.91 and a 1 year high of $72.50. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 2.62.

Ryan Specialty (NYSE:RYAN) last announced its quarterly earnings data on Thursday, April 30th. The company reported $0.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.43 by $0.04. The business had revenue of $795.23 million during the quarter, compared to analysts’ expectations of $781.44 million. Ryan Specialty had a return on equity of 46.41% and a net margin of 7.02%.The firm’s quarterly revenue was up 15.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.39 earnings per share. Analysts predict that Ryan Specialty will post 2.24 earnings per share for the current year.

Insider Transactions at Ryan Specialty

In related news, Director Patrick G. Ryan, Jr. purchased 25,500 shares of the business’s stock in a transaction on Monday, February 23rd. The stock was acquired at an average price of $39.96 per share, with a total value of $1,018,980.00. Following the completion of the acquisition, the director owned 428,295 shares of the company’s stock, valued at approximately $17,114,668.20. This trade represents a 6.33% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Corporate insiders own 52.03% of the company’s stock.

Hedge Funds Weigh In On Ryan Specialty

Hedge funds have recently made changes to their positions in the business. Westview Management dba Westview Investment Advisors purchased a new position in shares of Ryan Specialty during the 4th quarter valued at about $2,082,000. Beck Mack & Oliver LLC acquired a new stake in Ryan Specialty in the 3rd quarter worth about $2,818,000. JPMorgan Chase & Co. boosted its holdings in Ryan Specialty by 149.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 421,330 shares of the company’s stock worth $23,746,000 after buying an additional 252,582 shares during the last quarter. Geneva Capital Management LLC boosted its holdings in Ryan Specialty by 11.2% in the 3rd quarter. Geneva Capital Management LLC now owns 535,742 shares of the company’s stock worth $30,194,000 after buying an additional 53,810 shares during the last quarter. Finally, SG Americas Securities LLC acquired a new position in shares of Ryan Specialty during the 4th quarter worth approximately $20,776,000. Institutional investors own 84.82% of the company’s stock.

Ryan Specialty News Roundup

Here are the key news stories impacting Ryan Specialty this week:

• Positive Sentiment: Q1 results beat expectations — Ryan reported $0.47 EPS vs. $0.43 consensus and revenue of $795.2M (up 15.2% YoY) with organic revenue growth of 11.8%. The print shows continued demand across specialty lines and improved profitability metrics. Business Wire MarketBeat
• Neutral Sentiment: Company announced a quarterly dividend of $0.13 per share (annualized yield ~1.7%), payable May 26 to holders of record May 12 — modest income sign but unlikely to materially change near-term sentiment.
• Neutral Sentiment: Full Q1 earnings call transcript is available for investors digging into segment/expense details and management commentary on pricing, reinsurance and M&A strategy. Useful for assessing sustainability of organic growth. Earnings Call Transcript
• Negative Sentiment: Wells Fargo reaffirmed an “equal weight” rating but cut its price target to $31 from $42, removing upside cushion and signaling tepid near-term conviction; that downgrade likely contributed to selling pressure. Benzinga The Fly
• Negative Sentiment: Keefe, Bruyette & Woods cut its price target to $42 from $49 but kept an “outperform” rating — the lowered target reduces upside expectations despite the buy call, and adds to negative analyst repositioning. Benzinga

Ryan Specialty Company Profile

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.